Cargando…
Reply to letter to Editor written by Deora S, et al, regarding publication entitled “Rana N, Vijayvergiya R, Kasinadhuni G, et al. Comparison of radial versus femoral access using hemostatic devices following percutaneous coronary intervention. Indian Heart Journal. https://doi.org/10.1016/j.ihj.2021.04.006”
Autor principal: | Vijayvergiya, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424357/ https://www.ncbi.nlm.nih.gov/pubmed/34474773 http://dx.doi.org/10.1016/j.ihj.2021.06.020 |
Ejemplares similares
-
Reply to a letter to the editor written by Phansalkar et al, regarding publication entitled “Do we need a simplified model to predict outcomes in patients hospitalized with Acute Decompensated Heart Failure? Results from The Role of Sodium in Heart Failure Outcomes Prediction (‘SHOUT-PREDICTION’) study. Indian Heart J. 2021;73(4):458–463. doi:10.1016/j.ihj.2021.06.007”
por: Soni, Shishir, et al.
Publicado: (2022) -
Answer to Vieira et al. “Cytokine profile as a prognostic tool in coronavirus disease 2019”. Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006
por: Quartuccio, Luca, et al.
Publicado: (2021) -
Response to chicco et al. communication entitled ‘Management and outcomes of mammalian bite injuries during COVID-19 and implications for future practice’ Published: November 07, 2020DOI:https://doi.org/10.1016/j.bjps.2020.10.090
por: Friebel, T.R., et al.
Publicado: (2021) -
Response to the Letter-to-the Editor by Cohen et al. concerning our eNeurologicalSci article, Melamed-Gal, et al. Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone. eNeurologicalSci 2018;12:19–30.https://doi.org/10.1016/j.ensci.2018.05.006
por: Melamed-Gal, Sigal, et al.
Publicado: (2018) -
Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949
por: Rosendaal, Frits R.
Publicado: (2020)